Risk Factors of COVID-19 associated mucormycosis in Iranian patients: a multicenter study-Reference-Cited by-同舟云学术

Risk Factors of COVID-19 associated mucormycosis in Iranian patients: a multicenter study

Published:2024-08-22 Issue:1 Volume:24 Page:
ISSN:1471-2334
Container-title:BMC Infectious Diseases
language:en
Short-container-title:BMC Infect Dis

Author:

Eshraghi Bahram,Khademi Behzad,Mirmohammadkhani Majid,Khataminia Gholamreza,Ghahvehchian Hossein,Kiarudi Mohammad Yaser,Nabie Reza,Parandin Mohammadmehdi,Ghasemi Boroumand Paria,Mohammadi Rasoul,Zia Zahra,Karamirad Soroush,Jafarpour Soheyla,Fakoor Mostafa,Varshochi Mojtaba,Shahraki Kourosh,Memarzadeh Mohammad,Janipour Masoud,Mahdian Rad Atefe,Kashkouli Mohsen B,Shekarchian Farid,Manouchehri Vahideh,Khosravi Abbas,Abounoori Mahdi,Shahir Abazar,Sajjadi S. Mohammad Javad,Etezad Razavi Mohammad,Hosseini Nastaran-Sadat,Ebrahimi Fatemeh,Noorshargh Pegah,Forouhari Ali,Pourazizi Mohsen

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1186/s12879-024-09755-6.pdf

Reference40 articles.

1. García-Carnero LC, Mora-Montes HM. Mucormycosis and COVID-19-Associated Mucormycosis: Insights of a Deadly but Neglected Mycosis. J Fungi (Basel). 2022;8(5).

2. Jeong W, Keighley C, Wolfe R, Lee WL, Slavin MA, Kong DCM, et al. The epidemiology and clinical manifestations of mucormycosis: a systematic review and meta-analysis of case reports. Clin Microbiol Infect. 2019;25(1):26–34.

3. Prakash H, Chakrabarti A. Global Epidemiology of Mucormycosis. J Fungi (Basel). 2019;5(1).

4. Vaezi A, Moazeni M, Rahimi MT, de Hoog S, Badali H. Mucormycosis in Iran: a systematic review. Mycoses. 2016;59(7):402–15.

5. Özbek L, Topçu U, Manay M, Esen BH, Bektas SN, Aydın S, et al. COVID-19-associated mucormycosis: a systematic review and meta-analysis of 958 cases. Clinical Microbiology and Infection. 2023.